Literature DB >> 20127303

[Drug interactions].

V Hafner1, B Grün, C Markert, D Czock, G Mikus, W E Haefeli.   

Abstract

Drug-drug interactions can be used to enhance effectiveness but they are also a significant cause of adverse drug reactions. Alterations in liberation, absorption, distribution, metabolism, and excretion may all affect the pharmacokinetics of a drug. Cytochrome P450 enzymes and drug transporters like ABC-transporters determine the clearance of many drugs leading to alterations in therapeutic effect. In contrast pharmacodynamic drug interactions will alter drug effects in the absence of concentration changes of the co-administered drug. Alterations of a drug effect may require changes in dose to maintain the therapeutic effect.

Mesh:

Year:  2010        PMID: 20127303     DOI: 10.1007/s00108-009-2553-1

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  18 in total

1.  Interaction of citrus juices with felodipine and nifedipine.

Authors:  D G Bailey; J D Spence; C Munoz; J M Arnold
Journal:  Lancet       Date:  1991-02-02       Impact factor: 79.321

Review 2.  Clinical pharmacology of ibopamine.

Authors:  H Itoh
Journal:  Am J Med       Date:  1991-05-29       Impact factor: 4.965

3.  High prevalence of unknown co-medication in hospitalised patients.

Authors:  Karin Rieger; André Scholer; Isabelle Arnet; Frank T Peters; Hans H Maurer; Ingeborg Walter-Sack; Walter E Haefeli; Meret Martin-Facklam
Journal:  Eur J Clin Pharmacol       Date:  2004-06-10       Impact factor: 2.953

4.  Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study.

Authors:  Thomas Cuisset; Corinne Frere; Jacques Quilici; Raphael Poyet; Bénédicte Gaborit; Laurent Bali; Olivier Brissy; Pierre-Emmanuel Morange; Marie-Christine Alessi; Jean-Louis Bonnet
Journal:  J Am Coll Cardiol       Date:  2009-09-22       Impact factor: 24.094

Review 5.  Impact of OATP transporters on pharmacokinetics.

Authors:  A Kalliokoski; M Niemi
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

6.  Effect of simultaneous induction and inhibition of CYP3A by St John's Wort and ritonavir on CYP3A activity.

Authors:  V Hafner; M Jäger; A-K Matthée; R Ding; J Burhenne; W E Haefeli; G Mikus
Journal:  Clin Pharmacol Ther       Date:  2009-11-18       Impact factor: 6.875

7.  Undeclared exposure to St. John's Wort in hospitalized patients.

Authors:  Meret Martin-Facklam; Karin Rieger; Klaus-Dieter Riedel; Jürgen Burhenne; Ingeborg Walter-Sack; Walter E Haefeli
Journal:  Br J Clin Pharmacol       Date:  2004-10       Impact factor: 4.335

Review 8.  Drugs with anticholinergic properties: cognitive and neuropsychiatric side-effects in elderly patients.

Authors:  Iacopo Cancelli; Massimiliano Beltrame; Gian Luigi Gigli; Mariarosaria Valente
Journal:  Neurol Sci       Date:  2009-02-20       Impact factor: 3.307

9.  Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.

Authors:  P Michael Ho; Thomas M Maddox; Li Wang; Stephan D Fihn; Robert L Jesse; Eric D Peterson; John S Rumsfeld
Journal:  JAMA       Date:  2009-03-04       Impact factor: 56.272

Review 10.  Drug interaction between clopidogrel and proton pump inhibitors.

Authors:  Saira Chand Khalique; Angela Cheng-Lai
Journal:  Cardiol Rev       Date:  2009 Jul-Aug       Impact factor: 2.644

View more
  1 in total

Review 1.  [Drug-drug interactions in the elderly : Which ones really matter?].

Authors:  K Bitter; J F Schlender; R Woltersdorf
Journal:  Internist (Berl)       Date:  2016-07       Impact factor: 0.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.